← Open Payments lookup

VIVIAN SONA: Open Payments

NPI 1902358377 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,443 in 129 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $396 · 2025 $2,443

Food & beverage: $2,443
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.21$308
Janssen Pharmaceuticals, Inc19$304
ABBVIE INC.15$275
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)10$227
E.R. Squibb & Sons, L.L.C.11$210
Teva Pharmaceuticals USA, Inc.9$196
Axsome Therapeutics, Inc.10$187
Lundbeck LLC9$145
Corium, LLC4$131
Indivior Inc.6$123

Products named: REXULTI, VRAYLAR, CAPLYTA, COBENFY, Auvelity, INVEGA SUSTENNA, SPRAVATO, Azstarys.

Industry payments across TX — which companies pay providers there.